BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3933372)

  • 1. Effect of serum albumin on free fractions of phenobarbital and valproic acid in patients with convulsive seizures.
    Sadahiro N; Kodama S; Matsui T; Komatsu M; Matsuo T
    Brain Dev; 1985; 7(4):377-84. PubMed ID: 3933372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia?
    Kondo T; Ishida M; Kaneko S; Hirano T; Otani K; Fukushima Y; Muranaka H; Koide N; Yokoyama M; Nakata S
    Epilepsia; 1992; 33(3):550-4. PubMed ID: 1350534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of coadministered antiepileptic drugs on free fractions of phenobarbital and valproic acid in epileptic children.
    Kodama S; Sadahiro N; Yokoyama S; Komatsu M; Konishi H; Tanaka K; Tanaka K; Matsuo T
    Kobe J Med Sci; 1986 Oct; 32(5):141-9. PubMed ID: 3102832
    [No Abstract]   [Full Text] [Related]  

  • 4. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of coadministered antiepileptic drugs on serum phenobarbital concentrations in epileptic patients: quantitative analysis based on a suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2004 Dec; 27(12):2000-5. PubMed ID: 15577220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of valproic acid: influence of dose and comedication.
    May T; Rambeck B
    Ther Drug Monit; 1985; 7(4):387-90. PubMed ID: 3936236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic valproic acid therapy and incidence of increases in venous plasma ammonia.
    Haidukewych D; John G; Zielinski JJ; Rodin EA
    Ther Drug Monit; 1985; 7(3):290-4. PubMed ID: 3931312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinicopharmacological study of serum sodium valproate free level in children with epilepsy].
    Furuya M; Hashimoto K; Kamayachi S; Fujino O
    Nihon Ika Daigaku Zasshi; 1990 Dec; 57(6):513-23. PubMed ID: 2286644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
    Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
    Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid and phenytoin effects on serum proteins and immunoglobulins of epileptic patients.
    Garzón P; González-Cornejo S; Román-Maldonado S; Navarro-Ruiz A
    Gen Pharmacol; 1985; 16(4):411-3. PubMed ID: 2412936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
    Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
    Irshaid YM; Hamdi AA; Al Homrany M
    Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum protein binding of valproic acid in fetus-mother pairs throughout pregnancy: correlation with oxytocin administration and albumin and free fatty acid concentrations.
    Nau H; Krauer B
    J Clin Pharmacol; 1986 Mar; 26(3):215-21. PubMed ID: 3082943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients.
    Riva R; Albani F; Cortelli P; Gobbi G; Perucca E; Baruzzi A
    Ther Drug Monit; 1983 Jun; 5(2):191-6. PubMed ID: 6410545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Certain aspects of interaction between sodium valproate and other anticonvulsant drugs in the therapy of epilepsy in children.
    Sobaniec W
    Mater Med Pol; 1992; 24(2):115-9. PubMed ID: 1307765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of concurrent administration of sodium valproate on serum levels of primidone and its metabolite phenobarbital.
    Yukawa E; Higuchi S; Aoyama T
    J Clin Pharm Ther; 1989 Oct; 14(5):387-92. PubMed ID: 2511216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics.
    Yukawa E; To H; Ohdo S; Higuchi S; Aoyama T
    J Clin Pharmacol; 1997 Dec; 37(12):1160-7. PubMed ID: 9506012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
    May T; Rambeck B
    Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.